Overview
- VLCC must state in advertisements and consent forms: “The CoolSculpting Procedure is used for treatment of the focal fat deposits and not weight loss.”
- CCPA said VLCC’s promotions promised outcomes such as “Lose up to 600g and 7 cm in 1 session” and “Drop 1 size in 1 session permanently,” implying guaranteed results.
- The authority clarified that CoolSculpting is cleared only for reducing fat bulges in specific body areas and for individuals with a BMI of 30 or less, not for overall weight loss.
- CCPA noted the clinical evidence submitted to the US‑FDA involved 57 participants without Indian or Asian representation and that there is no US‑FDA endorsement specific to India.
- The watchdog earlier fined Kaya Rs 3 lakh for similar ads and warned clinics and service providers that further violations will lead to penalties, removal of misleading ads, and legal action.